Target Name: LOC105372441
NCBI ID: G105372441
Review Report on LOC105372441 Target / Biomarker Content of Review Report on LOC105372441 Target / Biomarker
LOC105372441
Other Name(s): LOC105372441 variant 1 | KLK3e | uncharacterized LOC105372441 | Uncharacterized LOC105372441, transcript variant 1

LOC105372441: A Promising Drug Target for HSP Protein

LOC105372441 (LOC105372441 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and intestines. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased temperatures, such as those encountered during exercise or other stressors.

The HSP protein is involved in a variety of cellular processes, including the regulation of protein folding, DNA replication, and stress responses. It is also involved in the detoxification of harmful substances, such as those that are present in the environment or in the body.

LOC105372441 variant 1 is a specific variant of the HSP protein that has been identified as a potential drug target. This is because it is able to interact with small molecules, such as drugs, which can modulate its activity and potentially lead to therapeutic benefits.

One of the key reasons why LOC105372441 is a promising drug target is because it is involved in a variety of important cellular processes that are critical for maintaining the health and function of the body. For example, it is involved in the regulation of protein folding, which is important for the production and function of many proteins that are essential for life. It is also involved in stress responses, which are critical for the regulation of cellular processes that are necessary for survival in the face of environmental stressors.

In addition to its involvement in cellular processes, LOC105372441 is also involved in the detoxification of harmful substances. This is important because many harmful substances, such as those that are present in the environment or in the body, can have toxic effects on the body. The HSP protein is involved in the detoxification of these substances, which can help to protect the body from the harmful effects of these substances.

The potential benefits of LOC105372441 as a drug target are significant. Because it is involved in a variety of important cellular processes that are critical for the health and function of the body, modulating its activity with small molecules could have a wide range of therapeutic applications. For example, LOC105372441 could potentially be used to treat a variety of diseases, such as heart disease, diabetes, and cancer, by modulating its activity to promote healthy cellular processes.

In addition to its potential therapeutic applications, LOC105372441 is also an attractive drug target because it is relatively stable and has a low potential for toxicity. This is important because stability and low toxicity are important considerations for drug development, as they can help to ensure that a drug is both effective and safe for use.

Overall, LOC105372441 is a promising drug target because of its involvement in important cellular processes and its potential therapeutic applications. Further research is needed to fully understand its potential as a drug and to develop safe and effective treatments.

Protein Name: Uncharacterized LOC105372441

The "LOC105372441 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372441 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660